Trial Profile
Strategy Phase III Intergroup Study for Chemotherapy of the Metastatic or Locally Advanced Cancers of the Stomach.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Mar 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Epirubicin (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Oct 2010 Status changed from active, no longer recruiting to completed.
- 08 Oct 2010 Primary endpoint 'Time to treatment failure' has been met.
- 08 Oct 2010 Final results presented at the 35th Congress of the European Society for Medical Oncology.